Charles River Labs Adds New Directors, Approves Compensatory Plans
Ticker: CRL · Form: 8-K · Filed: May 23, 2025 · CIK: 1100682
Sentiment: neutral
Topics: board-changes, governance, officer-compensation
Related Tickers: CRL
TL;DR
CRL adds two new board members and updates exec pay plans.
AI Summary
Charles River Laboratories International, Inc. announced on May 20, 2025, the election of Dr. David L. Ebersman and Ms. Jennifer L. Smith to its Board of Directors, effective immediately. The company also disclosed compensatory arrangements for certain officers and submitted matters to a vote of security holders. These changes are effective as of May 20, 2025.
Why It Matters
The addition of new directors can signal strategic shifts or enhanced governance, while changes in compensatory arrangements may impact executive motivation and future company performance.
Risk Assessment
Risk Level: low — The filing primarily concerns board appointments and routine corporate governance matters, with no immediate financial risks indicated.
Key Players & Entities
- Charles River Laboratories International, Inc. (company) — Registrant
- Dr. David L. Ebersman (person) — Newly Elected Director
- Ms. Jennifer L. Smith (person) — Newly Elected Director
- May 20, 2025 (date) — Effective date of board changes
FAQ
Who were the individuals elected to the Board of Directors?
Dr. David L. Ebersman and Ms. Jennifer L. Smith were elected to the Board of Directors.
When were the board changes effective?
The election of the new directors was effective as of May 20, 2025.
What other items were reported in this 8-K filing?
The filing also reported on compensatory arrangements of certain officers and the submission of matters to a vote of security holders.
What is the principal business address of Charles River Laboratories International, Inc.?
The principal executive office is located at 251 Ballardvale Street, Wilmington, Massachusetts 01887.
What is the SIC code for Charles River Laboratories International, Inc.?
The Standard Industrial Classification code is 8731, for SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 by Dr. David L. Ebersman regarding CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).